Idexx Laboratories Shareholders Approve Governance and Meeting Reforms

Idexx Laboratories ( (IDXX) ) just unveiled an announcement.

At the May 12, 2026 annual meeting, IDEXX Laboratories shareholders approved amendments to its Certificate of Incorporation to declassify the board over three years, moving to annual director elections starting in 2029, and to grant shareholders owning at least 25% of shares for at least one year the right to request a special meeting. A corresponding Certificate of Amendment was filed in Delaware and, effective May 13, 2026, the company also adopted Amended and Restated By-Laws aligning governance provisions and adding detailed procedures for special meeting requests.

Shareholders re-elected directors Daniel M. Junius, Lawrence D. Kingsley and Sophie V. Vandebroek as Class II directors with terms expiring in 2029, ratified PricewaterhouseCoopers LLP as independent auditor, and approved on an advisory basis executive compensation, while a separate shareholder proposal to broaden special meeting rights was voted down. The votes signal strong support for board-sponsored governance reforms that modestly expand shareholder rights while maintaining the company’s preferred framework for calling special meetings, shaping IDEXX’s governance profile in ways likely to be closely watched by investors and governance advocates.

The most recent analyst rating on (IDXX) stock is a Buy with a $675.00 price target. To see the full list of analyst forecasts on Idexx Laboratories stock, see the IDXX Stock Forecast page.

Spark’s Take on IDXX Stock

According to Spark, TipRanks’ AI Analyst, IDXX is a Outperform.

The score is primarily supported by strong profitability and cash flow with a de-risked balance sheet, reinforced by a confident earnings update that raised 2026 guidance. Offsetting these positives are weak technical trends (price below key moving averages with negative MACD) and a premium valuation (P/E ~54.6), with a minor added concern from the executive departure.

To see Spark’s full report on IDXX stock, click here.

More about Idexx Laboratories

IDEXX Laboratories, Inc., based in the veterinary and diagnostics industry, develops diagnostic and software products and services for companion animal veterinary practices, livestock and poultry, water testing and other related markets. The company focuses on providing advanced diagnostic tools and practice-management solutions that support veterinarians and animal health professionals worldwide.

Average Trading Volume: 547,170

Technical Sentiment Signal: Hold

Current Market Cap: $42.03B

See more data about IDXX stock on TipRanks’ Stock Analysis page.